11 patients received a combination of cisplatin and doxorubicin, and 1 patient received carboplatin and docetaxel. 83% (10/12) of the BRCA1-carriers achieved pCR. This results were comparable to existing results found in similar studies.No information about BC subtype among the study population and the toxicity of the chemotherapy was not evaluated. Here, BRCA1 is linked to breast cancer.